Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$75.00
Provider: GlobalData
$50.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BioPorto A/S Issues FY 2013 Financial Guidance


Monday, 25 Mar 2013 12:36pm EDT 

BioPorto A/S announced that it expects to report fiscal year 2013 revenue to be on par with fiscal year 2012. The Company also expects a loss in fiscal year 2013 and it is expected to be slightly greater than in fiscal year 2012 due to the initiation of clinical trials. The Company reported fiscal year 2012 revenue of DKK 17.9 million and fiscal year 2012 net loss of DKK 13.9 million. 

Related Company News

Company Quote

2.14
-0.04 -1.83%
10:59am EDT